Please use this identifier to cite or link to this item:
https://doi.org/10.1002/ccr3.2928
| Title: | Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir(R) therapy: A case report. |
| Authors: | Pumpure, Elizabete Dručka, Eva Kigitoviča, Dana Meškauskas, Raimundas Isajevs, Sergejs Nemiro, Ineta Rasa, Agnija Olmane, Evija Zablocka, Tatjana Alberts, Pēteris Doniņa, Simona |
| Keywords: | ECHO-7 virus;melanoma;oncology;oncolytic virus;Rigvir;uterine cervix |
| Issue Date: | 22-May-2020 |
| Abstract: | Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good. |
| DOI: | https://doi.org/10.1002/ccr3.2928 |
| Appears in Collections: | Publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy A case report.pdf | 1.22 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.